Cowen analyst Gary Taylor lowered the firm’s price target on Humana to $581 from $647 and keeps an Outperform rating on the shares. The analyst updated his model for 4Q22 results the business resegmentation and the 2024 Advance Notice.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on HUM:
- Humana price target lowered to $575 from $635 at Credit Suisse
- Humana price target lowered to $590 from $625 at Stephens
- Humana price target lowered to $620 from $645 at UBS
- Humana appoints Sanjay Shetty to lead health care services business
- Humana sees FY23 adjusted EPS ‘at least’ $28.00, consensus $28.00